Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)
Merck Sharp & Dohme Corp.
Radboud University (RUNMC)

      The purpose of the study is to investigate whether there is an interaction occurs between
      etoposide and aprepitant in patients with testis carcinoma treated with the standard BEP
      regimen.

      Also to determine how long treatment with aprepitant is necessary in BEP regimen for 5
      consecutive days.
    
Drug